Press releases

 

Media presence is a key part of making society aware of developments in biotechnology and its benefits. AseBio makes this platform available to members so they can share their press releases, alongside those the association posts regularly. If you are a journalist interested in learning more about the biotechnology sector, contact us at AseBio.

 

Search engine
Partners

New investors include 4BIO Capital, UPMC Enterprises, Jeito Capital and Ysios Capital

Partners

“New technologies are a key element of digital transformation in the healthcare sector", Ricard Sagués, Business Development & Marketing Director at Asphalion

Partners

The OSD is an annual initiative whereby the company's employees devote part of their working hours to carry out activities that can have a positive impact on society

Partners

The poster is entitled “Repurposing of Eravacycline for the Treatment of SARS-CoV-2 Infections” and outlines pre-clinical data demonstrating that Eravacycline is a potent inhibitor of the SARS-CoV-2 3CL protease

Partners

Paper describes mechanism of differentiation in patients and first antileukemic responses

Partners

Designating it as one of the most promising private biotechnology companies in the industry

Partners

Oncoheroes Biosciences is pleased to announce that the United States Food and Drug Administration (FDA) has granted the designation of rare pediatric disease to volasertib, an investigational treatment for rhabdomyosarcoma

Partners

Triple combination of iadademstat plus carboplatin-etoposide produced an objective response rate of 40% and mean average response of 4.5 months

AseBio

Spain is ranked 9th in scientific production in biotechnology and has the highest percentage of scientific papers in high-impact journals of any country: 83.3%